BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

655 related articles for article (PubMed ID: 6288359)

  • 1. Corticotropin releasing factor (CRF): effects on the release of pro-opiomelanocortin (POMC)-related peptides by human anterior pituitary cells in vitro.
    Chan JS; Lu CL; Seidah NG; Chretien M
    Endocrinology; 1982 Oct; 111(4):1388-90. PubMed ID: 6288359
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synergistical effects of ovine corticotropin-releasing factor (CRF) and arginine vasopressin (AVP) on the release of pro-opiomelanocortin (POMC) related peptides by pituitary adenoma of a patient with Nelson's syndrome in vitro.
    Chan JS; Gaspar L; Iguchi H; Seidah NG; Ling N; Chrétien M
    Clin Invest Med; 1984; 7(4):205-8. PubMed ID: 6335868
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential control of the release of pro-opiomelanocortin-derived peptides from the pars intermedia of the rat pituitary. Response to serotonin.
    Randle JC; Moor BC; Kraicer J
    Neuroendocrinology; 1983 Aug; 37(2):131-40. PubMed ID: 6310431
    [No Abstract]   [Full Text] [Related]  

  • 4. Secretion of pro-opiocortin peptides from isolated perfused rat pars intermedia cells.
    Jackson S; Lowry PJ
    Neuroendocrinology; 1983 Oct; 37(4):248-57. PubMed ID: 6138722
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Secretion pattern of pro-opiomelanocortin-derived peptides by a pituitary adenoma from a patient with Cushing's disease.
    Shibasaki T; Masui H; Sato G; Ling N; Guillemin R
    J Clin Endocrinol Metab; 1981 Feb; 52(2):350-3. PubMed ID: 6257745
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Release of pro-opiomelanocortin-derived peptides from the pars intermedia and pars distalis of the rat pituitary: effect of corticotrophin-releasing factor and somatostatin.
    Kraicer J; Gajewski TC; Moor BC
    Neuroendocrinology; 1985 Nov; 41(5):363-73. PubMed ID: 2865690
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of peptides derived from pro-opiomelanocortin in the biological fluids of a patient with Nelson's syndrome.
    Gaspar L; Chan JS; Seidah NG; Chrétien M
    Clin Invest Med; 1985; 8(2):167-75. PubMed ID: 3009068
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Concomitant secretion of adrenocorticotropin, beta-endorphin, and gamma-melanotropin from perfused pituitary tumor cells of Cushing's disease: effects of lysine vasopressin, rat median eminence extracts, thyrotropin-releasing hormone, and luteinizing hormone-releasing hormone.
    Oki S; Nakao K; Tanaka I; Horii K; Nakai Y; Shimbo S; Watanabe M; Nakane T; Kuwayama A; Kageyama N; Imura H
    J Clin Endocrinol Metab; 1981 Jan; 52(1):42-9. PubMed ID: 6256404
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential release of proopiomelanocortin-derived peptides from the human pituitary: evidence from a panel of two-site immunoradiometric assays.
    Gibson S; Crosby SR; Stewart MF; Jennings AM; McCall E; White A
    J Clin Endocrinol Metab; 1994 Apr; 78(4):835-41. PubMed ID: 8157708
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of ovine corticotropin-releasing hormone and FK 33-824 (met-enkephalin analogue) on the secretions of proopiomelanocortin-derived N-terminal peptide, beta-lipotropin, beta-endorphin and adrenocorticotropin in patients with Addison's disease.
    Sekiya K; Nawata H; Kato K; Motomatsu T; Ibayashi H
    Endocrinol Jpn; 1986 Dec; 33(6):761-8. PubMed ID: 3034555
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Post-translational processing of pro-opiomelanocortin in the Brattleboro (di/di) rat pituitary.
    Canny BJ; Smith AI; Clements JA; Funder JW
    Neuroendocrinology; 1988 Dec; 48(6):603-10. PubMed ID: 2855104
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A pituitary tumor producing high molecular weight adrenocorticotropin-related peptides: clinical and cell culture studies.
    Fuller PJ; Lim AT; Barlow JW; White EL; Khalid BA; Copolov DL; Lolait S; Funder JW; Stockigt JR
    J Clin Endocrinol Metab; 1984 Jan; 58(1):134-42. PubMed ID: 6315755
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuroendocrine alterations in nude mice with a human lung carcinoma producing pro-opiomelanocortin, corticotrophin-releasing hormone and arginine vasopressin.
    Morano MI; de Antueno RJ; Niedfeld G; Estivariz FE
    Clin Endocrinol (Oxf); 1990 Mar; 32(3):349-62. PubMed ID: 2160874
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chronic stimulation of anterior pituitary cell cultures with CRF leads to the secretion of lipotropin.
    Ham J; Smyth DG
    Neuroendocrinology; 1986; 44(4):433-8. PubMed ID: 2950333
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Studies of the regulation of the hypothalamic-pituitary-adrenal axis in sheep with hypothalamic-pituitary disconnection. II. Evidence for in vivo ultradian hypersecretion of proopiomelanocortin peptides by the isolated anterior and intermediate pituitary.
    Engler D; Pham T; Liu JP; Fullerton MJ; Clarke IJ; Funder JW
    Endocrinology; 1990 Oct; 127(4):1956-66. PubMed ID: 1976094
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chromatographic characteristics of pro-opiomelanocortin-derived peptides from the rat transplantable tumour 7315a.
    Morano MI; Estivariz FE
    J Endocrinol; 1987 Mar; 112(3):417-25. PubMed ID: 3031191
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of chronic secretagogue exposure on pro-adrenocorticotropin/endorphin production and secretion in primary cultures of rat anterior pituitary.
    Wand GS; Eipper BA
    Endocrinology; 1987 Mar; 120(3):953-61. PubMed ID: 3492370
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dopaminergic mediation of the effect of elevated potassium on the release of pro-opiomelanocortin-derived peptides from the pars intermedia of the rat pituitary.
    Randle JC; Moor BC; Kraicer J
    Neuroendocrinology; 1983 Aug; 37(2):141-9. PubMed ID: 6193453
    [No Abstract]   [Full Text] [Related]  

  • 19. Clinical studies with synthetic ovine corticotropin-releasing factor.
    Orth DN; DeBold CR; DeCherney GS; Jackson RV; Sheldon WR; Nicholson WE; Uderman H; Alexander AN; Island DP; Rivier J
    Fed Proc; 1985 Jan; 44(1 Pt 2):197-202. PubMed ID: 2981741
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dopamine-inhibited release of prolactin and intermediate lobe-POMC-peptides: different modulation by opioids.
    Voigt KH; Frank D; Düker E; Martin R; Wuttke W
    Life Sci; 1983; 33 Suppl 1():507-10. PubMed ID: 6319905
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.